We are live on !
Find out more
Daniel Loeb Third Point
AUM
$4.68B
Turnover
50%
1-Year Est. Return
37.3%
Daniel Loeb is the founder of Third Point, an event-driven and activist-oriented hedge fund. He is known for pointed letters to management teams, catalyst-driven investing, and a flexible mandate across equities and credit. Loeb’s campaigns and portfolio shifts regularly generate attention beyond specialist hedge fund circles.
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+37.3%
3 Year Est. Return
+159.49%
5 Year Est. Return
+329.12%
10 Year Est. Return
+1,791.94%
AUM
$11.1B
AUM Growth
+$2.37B
(+27%)
Cap. Flow
+$2.38B
Cap. Flow % of AUM
Cap. Flow %
21.5%
Top 10 Holdings %
Top 10 Hldgs %
64.13%
Holding
54
New
12
Increased
13
Reduced
7
Closed
14
Avg Time Held
Equity + Options
0.6
years
Top 10 Avg Time Held
Equity + Options
0.5
years
Top 20 Avg Time Held
Equity + Options
0.5
years
Avg Time Held Equity only
0.6
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.46B |
| 2 |
Phillips 66
PSX
|
+$369M |
| 3 |
eBay
EBAY
|
+$297M |
| 4 |
Alibaba
BABA
|
+$287M |
| 5 |
Citigroup
C
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ally Financial
ALLY
|
+$269M |
| 2 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$197M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$189M |
| 4 |
Parker-Hannifin
PH
|
+$147M |
| 5 |
Broadcom
AVGO
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.79% |
| 2 | Consumer Discretionary | 15.74% |
| 3 | Financials | 10.87% |
| 4 | Materials | 10.65% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$234B
| $1.7B | 15.34% |
10,675,000
+9,350,000
| +706% | +$1.46B |
2014 Q2
2 quarters
|
|
|
2
Alibaba
BABA
$271B
| $1.04B | 9.38% |
10,000,000
+2,800,000
| +39% | +$287M |
2014 Q3
1 quarter
|
|
3
DuPont de Nemours
DD
$17.6B
| $1B | 9.05% |
8,687,384
| – | – |
2013 Q4
4 quarters
|
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $888M | 8.01% |
3,450,000
+575,000
| +20% | +$144M |
2014 Q1
3 quarters
|
|
|
5
Ally Financial
ALLY
$11.5B
| $709M | 6.39% |
30,000,000
-11,915,000
| -28% | -$269M |
2014 Q2
2 quarters
|
|
|
6
eBay
EBAY
$53.5B
| $561M | 5.06% |
23,760,000
+13,068,000
| +122% | +$297M |
2014 Q3
1 quarter
|
|
|
7
Phillips 66
PSX
$117B
| $358M | 3.23% |
+5,000,000
| New | +$369M |
2014 Q4
0 quarters
|
|
|
BID
8
DELISTED
Sotheby's
BID
| $287M | 2.59% |
6,650,000
| – | – |
2013 Q2
6 quarters
|
|
9
Dollar General
DG
$29.6B
| $283M | 2.55% |
4,000,000
| – | – |
2013 Q2
6 quarters
|
|
10
Liberty Global Class C
LBTYK
$2.62B
| $280M | 2.53% |
7,169,357
+618,048
| +9% | +$22.6M |
2013 Q2
6 quarters
|
|
|
11
Citigroup
C
$208B
| $271M | 2.44% |
+5,000,000
| New | +$265M |
2014 Q4
0 quarters
|
|
12
AB InBev
BUD
$163B
| $253M | 2.28% |
2,250,000
+250,000
| +13% | +$27.7M |
2014 Q1
3 quarters
|
|
13
Masco
MAS
$14.4B
| $252M | 2.27% |
11,380,000
+2,162,200
| +23% | +$44.6M |
2014 Q1
3 quarters
|
|
14
DELISTED
SUNEDISON, INC COM
SUNE
| $219M | 1.98% |
11,250,000
+5,250,000
| +88% | +$100M |
2014 Q3
1 quarter
|
|
15
Sensata Technologies
ST
$5.91B
| $210M | 1.89% |
4,000,000
-1,000,000
| -20% | -$48.5M |
2014 Q1
3 quarters
|
|
16
DELISTED
EMC CORPORATION
EMC
| $208M | 1.88% |
+7,000,000
| New | +$204M |
2014 Q4
0 quarters
|
|
17
Roper Technologies
ROP
$37.9B
| $203M | 1.83% |
1,300,000
| – | – |
2014 Q1
3 quarters
|
|
18
American Airlines Group
AAL
$7.86B
| $201M | 1.81% |
3,750,000
+1,000,000
| +36% | +$43.1M |
2014 Q1
3 quarters
|
|
19
Constellation Brands
STZ
$22.2B
| $196M | 1.77% |
2,000,000
-100,000
| -5% | -$9.16M |
2013 Q2
6 quarters
|
|
20
American International
AIG
$42.2B
| $196M | 1.77% |
+3,500,000
| New | +$188M |
2014 Q4
0 quarters
|
|
21
Delta Air Lines
DAL
$49.6B
| $189M | 1.71% |
+3,850,000
| New | +$162M |
2014 Q4
0 quarters
|
|
22
Williams Companies
WMB
$87.2B
| $180M | 1.62% |
4,000,000
+2,500,000
| +167% | +$128M |
2013 Q4
4 quarters
|
|
23
CF Industries
CF
$18.3B
| $177M | 1.6% |
3,250,000
-550,000
| -14% | -$29M |
2014 Q1
3 quarters
|
|
24
People Inc
PPLI
$2.89B
| $144M | 1.3% |
13,289,093
+2,098,278
| +19% | +$23.8M |
2014 Q2
2 quarters
|
|
25
Edgewell Personal Care
EPC
$1.29B
| $129M | 1.16% |
1,349,000
| – | – |
2014 Q3
1 quarter
|
|
Similar funds
TCIM
Daniel Loeb's Q4 2014 Portfolio in Review
As of Q4 2014, Daniel Loeb held 54 positions worth $11.1B, up 27% from $8.71B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Daniel Loeb deployed $2.38B of net new capital in Q4 2014, opening 12 new positions and adding to 13 existing holdings. Its largest new stake was Phillips 66: 5,000,000 shares worth $358M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Ally Financial, an estimated $269M trimmed.
- Daniel Loeb's largest Q4 2014 buy was Phillips 66: 5,000,000 shares worth $358M.
- Daniel Loeb added most to Amgen in Q4 2014, an estimated $1.46B increase.
- Daniel Loeb's biggest Q4 2014 reduction was Ally Financial, cutting an estimated $269M.
- Daniel Loeb fully exited Bed Bath & Beyond Inc in Q4 2014, selling an estimated $197M.
- Daniel Loeb's ten largest holdings make up 64% of its $11.1B portfolio in Q4 2014.
- Daniel Loeb opened 12 new positions and closed 14 in Q4 2014.
- Daniel Loeb's portfolio value rose 27% quarter-over-quarter to $11.1B.
Based on Third Point's 13F filing for Q4 2014, filed 13 Feb 2015.